In addition, we also identified a trend of increased CD86 levels in circulating CD1c+ and CD141+ cDC and NC-Mo, and this increase was not observed in pDC or in SF Mo subsets from patients with RA (Supplemental Figure 2, A–C). This evidence concerns the gene THBD and rheumatoid arthritis.